Back to search

Article

Clinical efficacy of sacubitril/valsartan in maintenance hemodialysis patients with HFpEF

2023-05-08

Abstract excerpt

<h4>Background: </h4> Heart failure (HF) is a common comorbidity in maintenance hemodialysis (MHD) patients, of which ejection fraction preserved heart failure (HFpEF) is the main cause, resulting in substantial mortality and morbidity. However, there are still no effective therapeutic agents available for HFpEF. Sacubitril/valsartan (SV) has been shown to significantly improve clinical symptoms and reverse ventri...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f43a0105-a106-513c-b7a7-ed7cb8cf4927
DOI
10.21203/rs.3.rs-2846449/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical efficacy of sacubitril/valsartan in maintenance hemodialysis patients with HFpEFDOI 10.21203/rs.3.rs-2846449/v1
Sacubitril-Valsartan and Its Results for the Treatment of Heart Failure with Preserved and Mildly Reduced Ejection FractionSemantic proximity
Safety of Roxadustat Combined with Epoetin Alfa in Hemodialysis Patients with Anemia: A Cohort StudySemantic proximity
Age and Multimorbidities as Poor Prognostic Factors for COVID-19 in Hemodialysis: a Lebanese National StudySemantic proximity
Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction SpectrumSemantic proximity
Ventricular remodeling with dapagliflozin in elderly women with HFpEF--a single center prospective studySemantic proximity
Observed Frequency and Clinical Management of Sodium Polystyrene Sul-fonate Treated Hyperkalemia in Patients with Chronic Heart Failure in a Private Center in Costa RicaSemantic proximity
Age-adjusted mortality from systolic heart failure (HFrEF) is almost double that of diastolic heart failure (HFpEF) over recent years, with significant racial disparitySemantic proximity
Efficacy and safety of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and hypotensionSemantic proximity
Are patients on chronic hemodialysis treatment protected against mortality due to COVID-19? A single-center retrospective cohort of patients hospitalized with COVID-19 requiring hemodialysis treatmentSemantic proximity
Clinical phenotypes according to diuretic combination in acute heart failure.Semantic proximity
SGLT2i, ARNi and Diuretic Use in Patients with Heart Failure Among the Preserved and Reduced Ejection Fraction: A Retrospective Observational StudySemantic proximity
Network analysis for elucidating the mechanisms of Shenfu injection in preventing and treating COVID-19 combined with heart failureSemantic proximity
Select a neighboring publication to make it the new centre.